Akorn gets warning letter from the FDA
January 09, 2019 at 08:04 AM EST
Akorn Inc said on Wednesday it received a warning letter from the U.S. Food and Drug Administration, after the company's Decatur, Illinois manufacturing facility was inspected by the regulatory authority in April and May, 2018.